Expression of MT2A in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

MT2A is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1802.14

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

4241.0

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	20049.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	18856.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	17693.7
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	17272.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	13295.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	11704.5
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	11606.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	11565.1
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	11342.8
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	11014.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	10793.5
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	10676.8
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	10038.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	9882.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	9264.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	9072.5
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	8539.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	8133.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	7657.5
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	7464.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	7412.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	7369.7
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	6946.2
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	6873.9
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	6727.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	6656.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	6522.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	6507.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	6409.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	6342.0
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	5985.8
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	5860.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	5795.6
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	5588.2
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	5343.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	5241.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	5192.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	5104.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5093.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4751.3
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	4622.9
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	4369.4
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4305.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	4181.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	4146.7
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	4104.4
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	4007.0
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3988.9
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	3901.3
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	3895.9
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3868.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	3824.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3818.7
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3789.0
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	3757.5
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	3738.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3684.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3630.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	3588.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	3580.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3567.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3560.6
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	3557.1
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	3491.8
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3463.5
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3377.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	3287.9
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3232.0
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	3186.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3166.2
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	3121.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2991.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2888.5
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2865.1
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2793.9
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	2784.2
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2765.8
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2738.4
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2591.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2564.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2523.7
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2490.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2479.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2455.2
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	2426.1
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2422.9
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2400.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2338.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2335.7
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2320.8
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2269.1
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2214.3
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2187.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2158.8
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2129.4
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2125.5
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2091.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2090.7
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2014.2
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2002.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2001.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1959.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1917.1
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1882.9
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1847.7
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1802.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1777.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1776.3
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1766.6
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1744.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1723.2
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1691.6
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1690.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1599.8
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1595.5
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1539.1
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1535.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1436.4
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1372.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1326.9
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1316.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1312.0
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1306.7
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1305.6
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1214.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1213.5
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1182.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1105.2
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1037.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	953.5
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	937.7
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	907.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	876.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	856.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	845.4
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	816.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	803.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	767.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	766.8
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	313.7
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	248.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

MT2A is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 208.66

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

269.6

Number of samples

Samples

Sample	Description	pTPM
AK178	N, NA, stage:NA, dead, 240 days	1089.4
AK055	N, NA, stage:NA, dead, 240 days	812.1
AK139	N, NA, stage:NA, dead, 270 days	712.4
AK091	N, NA, stage:NA, dead, 210 days	675.3
AK195	N, NA, stage:NA, dead, 390 days	668.3
AK183	N, NA, stage:NA, alive, 360 days	614.7
AK133	N, NA, stage:NA, dead, 360 days	611.1
AK072	N, NA, stage:NA, dead, 150 days	602.0
AK236	N, NA, stage:NA, dead, 360 days	593.2
AK035	N, NA, stage:NA, dead, 210 days	570.1
AK226	N, NA, stage:NA, dead, 360 days	522.2
AK188	N, NA, stage:NA, alive, 420 days	497.9
AK153	N, NA, stage:NA, dead, 240 days	495.9
AK205	N, NA, stage:NA, dead, 120 days	433.9
AK218	N, NA, stage:NA, dead, 180 days	406.7
AK068	N, NA, stage:NA, alive, 360 days	380.7
AK098	N, NA, stage:NA, dead, 660 days	298.0
AK089	N, NA, stage:NA, dead, 330 days	293.4
AK088	N, NA, stage:NA, dead, 360 days	292.0
AK049	N, NA, stage:NA, dead, 180 days	257.0
AK006	N, NA, stage:NA, dead, 360 days	229.0
AK100	N, NA, stage:NA, alive, 960 days	228.9
AK117	N, NA, stage:NA, dead, 210 days	227.5
AK051	N, NA, stage:NA, dead, 360 days	216.4
AK081	N, NA, stage:NA, dead, 180 days	215.1
AK123	N, NA, stage:NA, dead, 180 days	211.6
AK071	N, NA, stage:NA, dead, 540 days	205.7
AK076	N, NA, stage:NA, alive, 660 days	189.7
AK158	N, NA, stage:NA, dead, 360 days	186.0
AK099	N, NA, stage:NA, dead, 420 days	185.2
AK005	N, NA, stage:NA, dead, 240 days	178.2
AK185	N, NA, stage:NA, alive, 330 days	174.8
AK227	N, NA, stage:NA, alive, 300 days	167.9
AK085	N, NA, stage:NA, alive, 660 days	164.7
AK074	N, NA, stage:NA, alive, 300 days	160.1
AK165	N, NA, stage:NA, alive, 360 days	156.9
AK231	N, NA, stage:NA, dead, 240 days	147.1
AK041	N, NA, stage:NA, alive, 810 days	140.6
AK134	N, NA, stage:NA, dead, 360 days	127.1
AK053	N, NA, stage:NA, dead, 300 days	125.7
AK167	N, NA, stage:NA, dead, 180 days	119.9
AK156	N, NA, stage:NA, dead, 330 days	100.1
AK216	N, NA, stage:NA, dead, 360 days	98.1
AK142	N, NA, stage:NA, alive, 90 days	96.5
AK149	N, NA, stage:NA, dead, 420 days	94.7
AK102	N, NA, stage:NA, alive, 1740 days	92.7
AK015	N, NA, stage:NA, alive, 720 days	84.4
AK103	N, NA, stage:NA, alive, 1320 days	78.4
AK043	N, NA, stage:NA, alive, 660 days	69.3
AK079	N, NA, stage:NA, dead, 210 days	65.3
AK199	N, NA, stage:NA, alive, 1860 days	55.7
AK002	N, NA, stage:NA, dead, 570 days	48.5
AK173	N, NA, stage:NA, dead, 180 days	39.3
AK030	N, NA, stage:NA, dead, 120 days	34.1
AK003	N, NA, stage:NA, dead, 600 days	33.3
AK066	N, NA, stage:NA, alive, 960 days	27.1
AK124	N, NA, stage:NA, alive, 1920 days	26.6
AK213	N, NA, stage:NA, alive, 2010 days	12.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0093450003	Tumor	2.6
CPT0079790003	Tumor	1.6
CPT0093590003	Tumor	1.4
CPT0167640003	Tumor	1.4
CPT0206230003	Tumor	1.3
CPT0190360004	Tumor	1.3
CPT0087680003	Tumor	1.2
CPT0168080003	Tumor	1.1
CPT0189570004	Tumor	1.1
CPT0078580003	Tumor	1.0
CPT0125220003	Tumor	1.0
CPT0218690004	Tumor	0.9
CPT0225760003	Tumor	0.7
CPT0205890003	Tumor	0.6
CPT0127480003	Tumor	0.5
CPT0218830004	Tumor	0.5
CPT0093360003	Tumor	0.5
CPT0219080004	Tumor	0.5
CPT0217100003	Tumor	0.4
CPT0209440003	Tumor	0.4
CPT0093550003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0221180003	Tumor	0.4
CPT0168480003	Tumor	0.3
CPT0201710003	Tumor	0.3
CPT0123530003	Tumor	0.3
CPT0182500003	Tumor	0.3
CPT0204370003	Normal	0.3
CPT0217060003	Tumor	0.3
CPT0186100003	Tumor	0.2
CPT0224330003	Tumor	0.2
CPT0217190003	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0190240004	Tumor	0.2
CPT0218960004	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0218330004	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0218670003	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0189460003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0206330003	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0218890004	Tumor	-0.3
CPT0217880003	Tumor	-0.4
CPT0168590003	Tumor	-0.4
CPT0162020003	Tumor	-0.4
CPT0175060003	Tumor	-0.4
CPT0204420003	Normal	-0.5
CPT0224540004	Tumor	-0.5
CPT0206560003	Tumor	-0.5
CPT0204330003	Normal	-0.5
CPT0127420003	Tumor	-0.6
CPT0092440003	Tumor	-0.6
CPT0205780003	Tumor	-0.6
CPT0204360003	Normal	-0.6
CPT0205670004	Tumor	-0.6
CPT0224600003	Tumor	-0.6
CPT0204380003	Normal	-0.7
CPT0168830003	Tumor	-0.7
CPT0093510003	Tumor	-0.7
CPT0125510003	Tumor	-0.7
CPT0104220003	Tumor	-0.8
CPT0162100003	Tumor	-0.8
CPT0208980003	Tumor	-0.8
CPT0217430008	Tumor	-0.8
CPT0225730003	Tumor	-0.8
CPT0162140003	Tumor	-0.9
CPT0204390003	Normal	-0.9
CPT0205450004	Tumor	-0.9
CPT0204350003	Normal	-0.9
CPT0182550003	Tumor	-0.9
CPT0182580003	Tumor	-0.9
CPT0206450003	Tumor	-1.0
CPT0167530003	Tumor	-1.2
CPT0224390004	Tumor	-1.2
CPT0171580008	Tumor	-1.2
CPT0189850004	Tumor	-1.2
CPT0204410003	Normal	-1.2
CPT0204400003	Normal	-1.3
CPT0217710008	Tumor	-1.3
CPT0167860004	Tumor	-1.4
CPT0228220003	Tumor	-1.4
CPT0218770003	Tumor	-1.4
CPT0161730003	Tumor	-1.5
CPT0002410011	Tumor	-1.5
CPT0206780003	Tumor	-1.5
CPT0104330003	Tumor	-1.5
CPT0207030003	Tumor	-1.5
CPT0204340003	Normal	-1.5
CPT0064890003	Tumor	-1.6
CPT0217000004	Tumor	-2.0
CPT0125570003	Tumor	-2.0
CPT0207090003	Tumor	-2.1
CPT0089150003	Tumor	-2.1
CPT0206670004	Tumor	-2.2
CPT0071100003	Tumor	-2.2
CPT0064650003	Tumor	-2.2
CPT0189650004	Tumor	-2.3
CPT0087730003	Tumor	-2.3
CPT0087570003	Tumor	-2.5
CPT0216920008	Tumor	-2.5
CPT0206110003	Tumor	-2.5
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis